Section of General Practice
President-JoHN H. HuNT, M.A., D.M. [February 20, 1957] DISCUSSION ON THE MODERN OUTLOOK IN THE MANAGEMENT OF PULMONARY TUBERCULOSIS Dr. K. Neville Irvine:
BCG Vaccination
From my angle the modem outlook in the management of any preventable disease is its prevention. We have all read of the ravages of smallpox before vaccination; in the twenty-four years that I have been in general practice I have myself seen diphtheria practically wiped out by APT; I hope that I may live to see pulmonary tuberculosis similarly reduced to a rare condition by preventive measures.
The ideal method of eradicating tuberculosis is to remove all sources of infection; this is the line taken by our veterinary colleagues in producing tuberculin-negative herds. Unfortunately this is a slow and difficult procedure if you cannot slaughter infectious cases. In the meantime much may be done by protective measures for the uninfected. Better standards of living, less overcrowding and education in hygiene are matters with which we general practitioners deal daily; there is little fresh to discuss here.
In 1949 a new preventive measure was introduced into this country. Under the control of the Ministry of Health, BCG vaccine was released to approved vaccinators for use on especially exposed persons-nurses, medical students, and the contacts of known cases of tuberculosis; it did not enter the realm of general practice. But in 1953 it was released for the mass vaccination of one age-group of the entire population-the 13-year-olds. To-day the family doctor is having rapidly to read up a subject about which he was never taught as a student, so that he can answer the searching questions of anxious parents. It is for this reason that I am confining myself to this one aspect of the prevention of tuberculosis.
When we consider that about every five-hundredth person we meet in a bus is an unknown infectious case of tuberculosis, it is clear that our chances of becoming infected are great. Ninety-nine times out of a hundred our first encounter with the tubercle bacillus results only in a subclinical infection-thanks to our natural resistance. This subclinical infection stimulates the body to produce an acquired resistance in addition to our natural resistance, so that we are better protected from future outside infection; we have, however, no guarantee that our own subclinical infection may not develop into clinical disease later. In short, the first invasion with the tubercle bacillus is a boon if it does not produce progressive primary disease or a later endogenous spread. This is the whole object of deliberately giving a person a primary infection with BCG. BCG was a bovine tubercle bacillus fifty years ago, but it has long since been rendered non-pathogenic. Introduced as a live vaccine into the skin it multiplies for six weeks and then regresses. Being non-pathogenic, it does not produce progressive primary disease or a later endogenous spread-but it does produce acquired resistance to any subsequent virulent infection.
In BCG we have a valuable preventive weapon-if it is safe and effective. So far one case of lupus of the vaccination site, which rapidly responded to treatment, is the only misadventure reported in this country (Davies, 1955) . In the world literature there are 4 cases that have died as the result of BCG vaccination (Irvine, 1957) ; this is deplorable, but it must be remembered that a total of about 145 million BCG vaccinations have now been carried out in the world, which gives a mortality rate of one in 36 million. Between 1940 and 1949 in England and Wales alone there were 43 deaths from smallpox vaccination (Registrar-General, 1949) .
The First (Progress) Report of the Medical Research Council Trial of BCG (1956) gives the answer to the question of its efficacy; it shows that 4 out of 5 of the vaccinated were protected. This was in a group unexposed to known tuberculosis. In an epidemic of tuberculosis in a girls' school in Denmark where the exposure was heavy, 95% of the vaccinated were protected (Hyge, 1947) .
If then we accept that BCG vaccine is reasonably safe and that the protection it producesthough not so complete as with smallpox vaccination or diphtheria inoculation-is worth while, why do we not advocate that everyone should be vaccinated? The reason is that, unlike antidiphtheria inoculation, you cannot give BCG to susceptible and immune alike. BCG vaccination in the uninfected person is like smallpox vaccination in slow motion; if BCG is given to someone who has already been infected, the result is very different. An angry reaction begins within a few hours and may reach its height in two days; the site of vaccination rapidly breaks down and the BCG is ejected by the body defences in a profuse purulent discharge. This is known as Koch's phenomenon.
It is wise therefore to differentiate between the infected and uninfected before giving BCG vaccine; fortunately there is a test which will do this-the tuberculin test. Anyone who has been infected with the tubercle bacillus becomes allergic to tuberculin, usually within six weeks. All that is necessary is to apply tuberculin to the skin; if no reaction occurs by the third day he may safely be vaccinated.
There are several methods of applying tuberculin. You may inject it diluted between the layers of the skin (the Mantoux test), scratch it into the skin (the Pirquet test), apply it to the skin under plaster (Moro and jelly tests), or prick it into the skin with needles (the Heaf multiple-puncture test). I shall confine myself to this last and newest test, because in this I think we have the most practical of all the tuberculin tests from the general practitioner's point of view. Let me say at the outset that its main disadvantage is the cost of the Heaf apparatus with which it is given.' This carries six needles drawn up behind an end-plate in which there are six holes; on firing the gun the needles stab through the holes in the end-plate to project a set distance. It is sterilized by dipping the end-plate into a shallow tray of spirit and igniting it.
The test is performed by cleaning the skin of the forearm with acetone and placing on it a drop of special tuberculin2 (PPD 2 mg./ml. in 5000 glycerol with 0-5%0 phenol); this solution is both stable and difficult to contaminate. The drop of tuberculin is spread by the end-plate of the Heaf apparatus into a half-inch circle: the skin of the forearm is drawn taut with the left hand: the end-plate is held firmly in the centre of the tuberculin and the gun fired. No skill is required as the apparatus is mechanically adjusted to perform the same six punctures to the same depth each time (Heaf, 1951) .
The test should not be read before the third day and some workers claim that it is reliable even when read as late as the seventh (Townsend and Macdonald, 1955) . As with all tuberculin tests, skill is required to read the weaker results. It should be remembered that in most negative reactions the six punctures will still be clearly visible; they may even be surrounded by a ring of erythema and bear a tiny crust in the centre. This should cause no confusion as the criterion of the minimal positive reaction is palpable induration around at least four of the punctures. Usually the positive reaction is more definite than this and the six punctures will have coalesced to form a ring or a plaque of induration. If in doubt, call the result negative and retest if possible.
I have discussed this test in some detail because, though it is too new to have reached most textbooks, it is rapidly becoming popular. As a result you may one day be asked to read the result of this test in a 13-year-old kept away from school by illness. Moreover for those of us who can afford this apparatus, a foolproof tuberculin test that is applicable both to the infant and the adult is of great interest.
If a general practitioner is prepared to do a tuberculin test on his patients, should he not be given access to BCG vaccine so that he can vaccinate the negative reactors in his practice? Before answering this question I think I should make it clear that BCG vaccination is nothing like as simple as antidiphtheria inoculation. To begin with it is a live vaccine which should not be used more than fourteen days after manufacture: it comes from Copenhagen and has to be ordered at least two weeks in advance: it deteriorates if not kept in a refrigerator, is damaged by heat and killed by exposure to sunlight; it can contain no preservative and so any ampoule must be used within a short time of opening. The dose is one-tenth of a millilitre, so for accuracy a special long syringe is generally used. The BCG issued by the Ministry has to be injected intracutaneously which requires a special quarter-inch needle with a short bevel and a skill in a technique that few of us were taught in our student days; if the injection is accidentally given subcutaneously, a local abscess the size of a cherry is likely to appear six weeks later. The healthy infant that would be the first care of every family doctor is the greatest BCG headache of all; not only is a baby's 'Obtainable from Messrs skin extremely thin and tough, but it is in this age-group that glandular abscesses follow the most perfect vaccinations with distressing frequency. I feel, therefore, that our generation of general practitioners would be wise to leave BCG vaccination at the moment to specially trained vaccinators. As the number of approved vaccinators is not great-they are mostly chest physicians or school medical officers-they cannot be expected to take on any great extension of BCG vaccination. This is limiting wider use of the vaccine. The solution which I would advocate is that no medical student should in future reach qualification without having had practical training in tuberculin testing and BCG vaccination. Those of our generation who are keen on preventive medicine could also be given practical training in a short postgraduate course. By this means it should soon become possible for the Ministry to release BCG vaccine to the family doctor for use alongside his other preventive inoculations.
Meanwhile we must be prepared to give advice to the mother of the 13-year-old. Before vaccination he will be given an initial tuberculin test: what is the significance of a positive reaction? In a healthy boy this probably only means that he has had a subclinical infection at some time, but this is only a probability; the best way to be sure is to take a chest X-ray. A marked positive reaction is a warning to keep an eye on the boy for some time; the M.R.C. found four times more cases of tuberculosis developing later in fierce reactors than in mild. The fierce reactions are uncomfortable; a dressing of antihistamine ointment is useful.
Next, the negative reactor will be vaccinated with BCG. If a reaction occurs at the site of vaccination in the first week, refer him back to the vaccinator. Little should normally be visible for two weeks when a painless papule appears; this increases to a maximum at six weeks. The average papule measures 10 mm. across; it should not normally exceed 20 mm. Three-quarters of these papules will break down to an ulcer and discharge pus. The average diameter of the ulcer is 5 mm.; it should not normally exceed 10 mm. If a dressing has to be applied to protect the clothing, it should allow as much air to the ulcer as possible; do not occlude it with a plaster dressing or smother it with penicillin ointment. If he wants to go swimming, there is a waterproof rubber sleeve on the market' that he can pull over the dressing. If instead of a papule, an abscess the size of a cherry develops, it should be aspirated-not incised; the best plan is to refer it back to the vaccinator.
After the sixth week the vaccination reaction should begin to regress and ulcers should be healed by the tenth week. Large or indolent ulcers may be helped by exposure to sunlight, dusting with PAS or dressing with a special "BCG Reaction Ointment".2 A painless enlargement of the regional lymph glands normally occurs in 3 % of all vaccinations about the sixth week and may last for several weeks; the mother should be reassured and no action taken. Sometimes, however, three to twelve months after vaccination the glands break down to form a cold abscess. This harmless but distressing complication occurs in about 0 5% of infants vaccinated; it is fortunately uncommon in school children. It should be treated by repeated aspiration and replacement of the pus with streptomycinnever by simple incision, or a troublesome sinus may result. There is evidence to suggest that any injection given in the same arm within six months of BCG may precipitate a glandular abscess; for this reason it is wise always to give BCG in the right arm thus leaving the traditional left arm free for other inoculations.
With the possible exception of the very rare complication of lupus, all complications of BCG always heal in the end-even if they have been wrongly treated. You may with complete confidence continue to reassure both yourself and the anxious mother.
Some six to twelve weeks after vaccination the tuberculin test is repeated; this time it should be positive, showing that infection with BCG has taken place and the vaccination has been effective. This change from negative to positive is called "conversion" and this post-vaccination test is called the "conversion test". For school children in the Oxford Region, the conversion rate to a Heaf test is 99-2%; similar findings have been reported in other parts of the country and there is much discussion about whether conversion testing will be necessary in the future.
At intervals vaccinated persons may be followed up with further tuberculin tests to see that the vaccination is still effective; if the tuberculin test returns again to negativea process known as "reversion"-the person should be revaccinated. It is impracticable to go to these lengths with unexposed school children, but it is important that the full procedure should be carried out on those who are in continual contact with tuberculosis.
'Made by Messrs. Kleinerts, 91, New Bond Street, London, W.l.
2Glaxo Laboratories make a BCG Reaction Ointment (L.C.C. formula) containing in eachgram hydrocortisone acetate 10 mg. dihydro-streptomycin 5,000 units and isonicotinic acid hydrazide 50 mg. 23 487 It has been my part to discuss the most modem addition to the methods of preventing pulmonary tuberculosis-BCG vaccination; I am anxious that I should not give the impression that I consider it to be the whole answer to the problem. It is but one more weapon in our armament against tuberculosis-though, I submit, a most effective one. I would offer just one word of caution when discussing our "new" vaccine with European colleagues; Scandinavia has been using it for thirty years and France for thirty-six. 
Sir Geoffrey Marshall:
Chemotherapy This is a good time for us as clinicians to take stock of our methods of dealing with patients suffering from tuberculosis. The situation has been changing fundamentally as a result of the introduction of effective chemotherapy. Many more patients are being treated in their own homes, and beds in sanatoria are standing empty; whereas only a few years ago there were long lists of patients awaiting admission. The number of new cases notified annually in England and Wales has fallen only slightly, from 50,000 before the war to about 40,000 now; but the death-rate is only one-third of what it was in 1938. This is heartening, but 8,000 deaths per annum from tuberculosis, most of them preventible, should not give us an excuse for complacence. The pattern of mortality has changed. Prior to the war the highest mortality was in young women; now the bulk of the deaths are in elderly men-those in the sixties and seventies, many of whom have been hit hard by the social changes of the Welfare State.
The fall of the gross mortality must be attributed largely to earlier diagnosis by the widespread use of radiography and to more effective treatment, in the form of chemotherapy which followed the advent of streptomycin in 1948. Now let us consider how we should deal with various types of case, remembering that management of the patient, his dependants and contacts can never be satisfactory unless a large measure of the responsibility is kept in the hands of the general practitioner. Early diagnosis has been achieved in a great many cases by Mass Radiography. It is a procedure we should encourage, not least for men over 50 years of age. We can reassure the public who have been unduly alarmed by propaganda on the dangers of excessive radiation. There is no assessable risk to the subjects of chest radiography. The Minimal Lesion When X-ray films show normal lung fields apart from the presence of one or two discrete rounded opacities of not more than one centimetre in diameter, these are commonly called minimal lesions, and not infrequently these cases are kept under observation by periodical radiography, without treatment. Usually there is no sputum and no indication of toxxemia.
The X-ray appearance may improve or it may remain unaltered for a year or more. But at any time you may find a sudden change for the worse. Moreover if swabs from the larynx or juice from the stomach are taken when the lesions are first seen, and if these materials are cultured for ten weeks, tubercle bacilli will be found in about one-fifth of the cases. I believe that we should treat all these patients by chemotherapy as soon as the lesions are found. The drugs penetrate the lesion and eliminate the tubercle bacilli most effectively when the lesions are only a few weeks old. Moreover early treatment would prevent the development of bronchial stenosis, with permanent structural damage to the lungs.
Pleural Effusion
The contemporary treatment for this is chemotherapy and early and thorough aspiration. If fluid recurs it is usual to inject streptomycin into the pleural cavity after each aspiration.
Chemotherapy should be continued for twelve months at least in cases of minimal lesion and pleural effusion. Regular review with radiography should be maintained for several years.
In more advanced cases the main lesions are likely to be considerable areas of infiltration in the lungs, together with segmental atelectasis which is characterized by wedge-shaped or linear shadows in the lung fields. The presence of tuberculous cavities may be detectable only by tomography.
In all cases chemotherapy is an essential part of the treatment, and rest is necessary for a variable period of weeks or months. Whether treatment is to be carried out at home or in an institution will depend on individual circumstances. In all cases chemotherapy should be begun at home while awaiting admission to hospital. If the sputum is positive and there are children in the house, the patient should go to hospital. If the presence of a pleural effusion, or of cavitation in the lungs calls for constant observation or strict bed rest, hospital is the place for it. The mother and housewife will never rest with an easy mind in her own home, and she should go away until active disease has been arrested. Other patients may do very well at home, but precautions must be taken against spreading infection. There must be no visits by those susceptible to infection, and effective steps must be taken to sterilize sheets, pillow-cases and handkerchiefs.
With regard to the chemotherapy we have three effective drugs, any two of which may be given simultaneously. These drugs are streptomycin, PAS and Isoniazid. There are others, but they are too toxic for consideration here. It is usual to begin treatment with streptomycin by injection and one of the other two drugs by mouth. We must not give one drug by itself as this leads to the development of resistant strains of tubercle bacilli, with consequent danger to the patient and to the public. On the other hand there is little to be said for the administration of all three drugs at the same time. Give two at a time and give them in effective doses. For an adult we give intramuscular injections of streptomycin sulphate, 1 gram once a day on five to seven days a week. PAS is given by mouth on six days a week, 14 to 20 grams daily in divided doses; and Isoniazid is given by mouth in tablets of 100 mg. two or three times a day on six days a week.
As intramuscular injections are inconvenient when a patient resumes active life, we usually continue treatment with PAS and Isoniazid at that stage, and maintain chemotherapy for twelve months in the first instance, with shorter repeat courses at intervals thereafter.
In patients who are acutely ill, and in those who are intolerant of the drugs, great benefit is to be derived-as has been shown by Dr. L. E. Houghton-from giving preparations of the cortisone group together with the anti-tuberculous drugs. 
Sir Clement Price Thomas:
Modern Surgical Treatment I shall deal with my subject mainly from the point of view of the general principles guiding the form of treatment to be advised, and to indicate, by a consideration of cases treated, the reasons for such decisions.
Surgically speaking, after the beneficial general effects of drug therapy are accepted, the most important factor is the effect of the drugs on the bronchial disease; the healing of the disease in the bronchi produces one of two results, either the opening of the bronchi by the decrease in the thickness of the diseased bronchial mucosa leading to a decrease in the size of the cavity, and in favourable cases, its closure, or it leads to stenosis of the bronchi; this latter resulting from the fibrosis following up the healing of the disease, and the subsequent contraction of the fibrous tissue. Stenosis will only occur when the tuberculous process has involved the musculofibrous wall of the bronchus. These processes I believe to be the main factors in either the healing or blocking of tuberculous cavities. When stenosis affects the larger bronchi such as the lobar or main bronchi, mechanical problems ensue which are not strictly related to the tuberculous disease. One other factor resulting from the healing of tuberculous bronchial disease is that resection of the lung becomes a safer procedure in that the line of section of the bronchus will then be through healthy tissue.
There is a tendency to consider resection and relaxation operations as competitive procedures, instead of considering them as being complementary. As I shall show later, as a broad differentiation, resection should be reserved for tuberculous lesions which are either non-cavitated or have been converted from open lesions to closed lesions or, at least, into lesions which have ceased shedding tubercle bacilli, as judged by direct smears or cultures; on the other hand, open cavitated lesions, with a positive sputum, still are best treated by thoracoplasty, if the cavity be in such a position that closure can be anticipated.
The practical politics of the issue are as have been indicated by my colleagues. All patients, after a satisfactory diagnosis has been made on all three grounds, clinical, radiological and bacteriological (including the sensitivity of the organisms to the available drugs), should be started on chemotherapy, using always two of the available drugs, never one, in order to prevent the emergency of insensitive strains of bacilli. It is usual to use streptomycin as one of them at the outset. The length of treatment will depend on many factors: the extent and severity of the disease, the persistence or otherwise of a positive sputum, the closure or blocking of the cavities; but, generally speaking, treatment should be continued for as long as there is steady even progress, on clinical, radiological and bacteriological grounds. No patient, who has a positive sputum at the outset of the disease, should be submitted to resection before he has had at least three months' medical treatment, and in those with cavitation, a minimum of six months' pre-operative treatment is safer.
Admittedly other factors arise which may modify the above course, but it should be quite fully realized that to modify such a curriculum is to increase the potential risk to the patient.
The tables list a series of cases submitted to resection for pulmonary tuberculosis and personally operated upon. Table I shows the number of cases with the early and late mortality. It is noteworthy that there has been only one early death in the last three years and that from coronary thrombosis.
From Tables II and III , it will be seen that all of the 18 early deaths, with the one exception already referred to who had a solid lesion, occurred in patients who had open cavitated disease at the time of operation. By early death is meant those patients who died whilst in hospital, who were, in fact, never fit enough to leave. Some died quite some time post-operatively from some complication of the operation, most commonly bronchial fistula with a complicating empyema and spread of the disease.
As would be expected, the highest mortality accompanies the more complicated forms of the disease, empyema and stenosis with underlying open cavitated disease. Interestingly enough, destroyed lungs have a lower operative mortality than the former two, and this I believe to be due to the fact that in quite an appreciable number of this latter group, the tuberculous disease has burnt itself out. In other words, the patient has conquered the tuberculous infection at the expense of gross anatomical destruction.
If the whole group of patients with cavitated disease be alone considered, 85 in all, 17 patients died in hospital, a mortality rate of 20%.
This high mortality rate was, without doubt, due to operating on patients with open cavitated disease and a positive sputum at a time when the necessity for prolonged preoperative chemotherapy in such cases was not properly appreciated. I believe that the time-duration of such treatment, with adequate daily dosage, is of more significance than the total quantitative dosage. There can be no question that the whole success of surgical intervention, especially resection, depends on adequate and effective pre-operative treatment. In a certain number of patients, cavity closure and sputum conversion do not occur even with prolonged treatment, due commonly to drug resistance of the organisms; then again adequate treatment cannot be given owing to the patient's sensitivity to the drugsin one case, the patient developed agranulocytosis. In any case, whatever the cause of failure, in such cases, if there is a reasonable chance of cavity closure, thoracoplasty is far and away the safer procedure. If the cavity, however, is in such a place as to preclude reasonable expectation of closure, for example in the basic segments of the lower lobe or in the middle lobe, then the risk may have to be undertaken but the risk should be clearly recognized.
490
It will be agreed that the aim in view is the cure of the patient's disease with as little risk as possible, and the choice of treatment lies in the accurate assessment of these two factors.
Tables IV, V and VI list the types of operative intervention and demonstrate the same points relative to open cavitated disease, and that the mortality is greater in proportion to the extent of the intervention.
The end-results of resection cannot yet be accurately assessed. It will be seen that there are 10 late deaths, this giving a mortality of 2 8 % in the 348 who survive after leaving hospital, and of these, about two-thirds die of a disease other than tuberculosis. The endresults are difficult to report owing to the short time available since resection became general (with four exceptions, the longest survival is eight years); and also to the inadequate follow-up at the time of reporting. At the time of writing, however, of those followed up about 3% are classified as being poor, about 84% as good, and about 13% as fair. I feel reasonably certain that in the latter two groups, the majority of those considered fair, in due course, will eventually merge into those considered to be good. I suggest that the conclusions to be drawn from the foregoing experience are that resection of the lung for tuberculosis can be rendered a safer procedure, provided adequate and effective chemotherapy is carried out before operation is undertaken, and that more than probably it will be attended by good long-term results. 491 E D
